Cite

EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapy

MLA

Pauline Hulo, et al. EGFR Mutation-Positive NSCLC: Factors to Consider When Deciding First-Line Therapy. May 2020. EBSCOhost, https://doi.org/10.1080/14737140.2020.1757439⟩.



APA

Pauline Hulo, Jaafar Bennouna, Marc G. Denis, & Dahna Coupez. (2020). EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapy. https://doi.org/10.1080/14737140.2020.1757439⟩



Chicago

Pauline Hulo, Jaafar Bennouna, Marc G. Denis, and Dahna Coupez. 2020. “EGFR Mutation-Positive NSCLC: Factors to Consider When Deciding First-Line Therapy,” May. doi:10.1080/14737140.2020.1757439⟩.